Ouedraogo, H. G., Matteelli, A., Sulis, G., Compaore, T. R., Diagbouga, S., Tiendrebeogo, S., . . . Kouanda, S. (2020). Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis–HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per week. BMC.
Chicago Style (17th ed.) CitationOuedraogo, Henri Gautier, et al. Pharmacokinetics of Plasma Lopinavir and Ritonavir in Tuberculosis–HIV Co-infected African Adult Patients Also Receiving Rifabutin 150 or 300 mg Three Times Per Week. BMC, 2020.
MLA (8th ed.) CitationOuedraogo, Henri Gautier, et al. Pharmacokinetics of Plasma Lopinavir and Ritonavir in Tuberculosis–HIV Co-infected African Adult Patients Also Receiving Rifabutin 150 or 300 mg Three Times Per Week. BMC, 2020.
Warning: These citations may not always be 100% accurate.